This year’s program will examine how the pharmaceutical and life sciences industries are responding in real time to new developments in regulation, market dynamics, and global trade. Through interactive discussion and diverse perspectives, attendees will gain valuable insights on how businesses, their advisors, and investors are navigating change while continuing to deliver innovation and impact for Canadians.

Panel Discussion: Reacting in Real Time: How Are the Pharmaceutical and Life Sciences Industries Adapting to Trade in 2025 – Navigating Regulatory Challenges

Moderated by Wendy Wagner, Partner, Gowling WLG, this discussion will feature leading voices from across the industry — including Anne Woods (RBCx) and James Blonde (Roche Canada) — who will share insights on how organizations are adapting to uncertainty, strengthening resilience, and positioning for sustainable growth in a shifting market.